a non-carcinomatous nasopharyngeal mass with cervical lymphadenopathy

Clicks: 162
ID: 216779
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The nasopharynx is the commonest site for adenoid-related pathology. The second common disease in the area is nasopharyngeal carcinoma. Uncommonly other lesions, such as Thornwaldt cyst, lymphoma, or a granulomatous disease can be found. The case of nasopharyngeal tuberculosis (TB) is not well reported, especially if the lesion occurred at the fossa of Rosenmuller (FOR) with the presence of cervical lymphadenopathy. It may be under diagnosed because of its rarity and it does not produce pathognomonic symptoms of TB. We report a case of a 14-year-old Malay girl who presented with left neck swelling for 2 weeks and sore throat. A rigid nasoendoscopy was performed and revealed fullness over the right FOR. A biopsy was reported as chronic granulomatous inflammation suggestive of TB. Ziehl-Nielsen stain for acid-fast bacilli was positive. The patient was started on anti-tubercular drugs and 2-week follow up later showed significant mass regression.
Reference Key
2018journala Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Aishah Harizah Abdullah Alwi ;Mimi Ezreena Esa ;Khairul Azhar M. Rajet ;Khairudin Abdullah ;Siti Zarqah Omar ; Irfan Mohamad
Journal journal of pioneering medical sciences
Year 2018
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.